KIORA PHARMACEUTICALS INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Kiora Pharmaceuticals Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Kiora Pharmaceuticals Inc Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $72.6K, a 288% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $72.6K +$53.9K +288% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $82.3K +$32.1K +63.9% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $94.3K +$9.8K +11.6% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $107K -$10.1K -8.64% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $18.7K -$129K -87.3% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $50.2K -$125K -71.3% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $84.5K -$73.8K -46.6% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $117K -$92.4K -44.1% Dec 31, 2022 10-K 2024-03-25
Q3 2022 $147K -$112K -43.1% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $175K -$133K -43.1% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $158K -$84.4K -34.8% Mar 31, 2022 10-Q 2022-07-08
Q4 2021 $209K +$125K +150% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $259K Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $308K Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $243K Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $83.9K Dec 31, 2020 10-K/A 2022-07-07
Q2 2019 $110K Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $97.4K Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $0 Dec 31, 2018 10-Q 2019-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.